Epstein invested in Coinbase in early funding round
Jeffrey Epstein invested $3 million in crypto exchange Coinbase in 2014, with newly released US Justice Department emails indicating senior company figures were aware of his involvement.

Finance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.
Jeffrey Epstein invested $3 million in crypto exchange Coinbase in 2014, with newly released US Justice Department emails indicating senior company figures were aware of his involvement.
Prediction market platforms Polymarket and Kalshi are staging free grocery events in New York City as state lawmakers consider proposals that could restrict their operations.
Institutional crypto derivatives provider Rails has launched onchain vaults on the Stellar to give brokerages and fintechs access to perpetuals trading with segregated collateral and cryptographic proofs.
Crypto is becoming too closely aligned with Wall Street and traditional finance, risking a dilution of the industry’s original ethos, according to a co-founder of blockchain firm Gnosis.
US investigators are intensifying scrutiny of Iran’s expanding crypto sector amid concerns digital assets are being used to evade international sanctions.
G11 Resources (ASX:G11) commenced its maiden drilling program at the Zig Zag Cu-Au prospect within the 100% owned Sedgwick Project.
Centuria Office REIT (ASX:COF) has roared back into the black, delivering a statutory net profit of $62 million for the first half of FY26.
Jumbo Interactive (ASX:JIN) has signaled a robust start to the 2026 fiscal year, reporting a preliminary underlying group EBITDA of $37.5 million for the first half.
Global electric vehicle pioneer Vmoto (ASX:VMT) has signaled a turnaround in its latest market update, reporting a 68.3% leap in sales for the final quarter of 2025.
Pfizer (NYSE:PFE) announced positive topline results from the Phase 2b VESPER-3 study evaluating monthly maintenance dosing of its fully-biased, ultra-long-acting injectable GLP-1 receptor agonist PF’3944 (nexiguran ziclumeran) in adults with obesity or overweight without type 2 diabetes.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy